Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FDD87
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,207
Award facts
- Contract value 100% obligated
- $14,207.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,207.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The award, issued on October 30, 2025, with an ultimate completion date of November 21, 2025, carries firm fixed-price terms and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was awarded on November 13, 2025.
The PPV-G GEN V contract, with a ceiling value of $499.999 billion and completion date of December 31, 2036, represents a critical component of the broader $30.3 billion acquisition strategy designed to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across multiple delivery orders for diverse pharmaceutical categories—including specialty biologics, oncology treatments, vaccines, and contraceptive devices—positions the company as a key regional prime vendor within the Defense Logistics Agency's global medical supply chain. No subcontractors have been identified in the award documentation.
Quick answers
Who was awarded contract SPE2DB26FDD87?
SPE2DB26FDD87 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FDD87 worth?
The government has obligated $14,207 on SPE2DB26FDD87.
Is contract SPE2DB26FDD87 an order under another contract?
Yes. SPE2DB26FDD87 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB26FDD87 competed?
The extent of competition for SPE2DB26FDD87 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award